Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT01619813 · COMPLETED
Trial details
- NCT number
- NCT01619813
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-14
- Primary completion
- 2016-04-26
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.